001067.KS
JW Pharmaceutical Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 50,200.00
+0.00%Latest reported
- Last report date
- May 15, 2026
- EPS actual
- KRW 1.1K
- EPS estimate
- —
- Revenue actual
- KRW 199.9B
- Revenue estimate
- KRW 202.5B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 15, 2026 | — | KRW 1.1K | — | KRW 199.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 15, 2026